(Q36688967)

15 August 2017

1 reference

title

Advances in the diagnosis and management of neurocysticercosis (English)

1 reference

15 August 2017

1 reference

A Clinton White

3

0 references

author name string

Jose A Serpa

series ordinal

1

1 reference

15 August 2017

Linda S Yancey

series ordinal

2

1 reference

15 August 2017

publication date

1 December 2006

1 reference

Expert Review of Anti-infective Therapy

15 August 2017

published in

1 reference

15 August 2017

volume

4

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

1051-1061

1 reference

Taenia solium cysticercosis

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Neurocysticercosis: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Control of Taenia solium taeniasis/cysticercosis: from research towards implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

The current status of neurocysticercosis in Eastern and Southern Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Neurocysticercosis in the United States: review of an important emerging infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Epileptogenic activity of granulomas associated with murine cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Neurocysticercosis: updated concepts about an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Calcific neurocysticercosis and epileptogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Cysticercosis and epilepsy: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Proposed diagnostic criteria for neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Characterization and cloning of T24, a Taenia solium antigen diagnostic for cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Current consensus guidelines for treatment of neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Treatment of neurocysticercosis: current status and future research needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Endoscopic management of supratentorial ventricular neurocysticercosis: case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Species identification after treatment for human taeniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

Taenia solium: A Cysteine Protease Secreted by Metacestodes Depletes Human CD4 Lymphocytes in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.1051

10.1586/14787210.4.6.1051

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference